Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2025-06-02 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Ipsen S.A. - Lancement du programme de rachat d'actions
Transaction in Own Shares Classification · 1% confidence The document is a press release titled "Ipsen lance un programme de rachat d'actions pour couvrir son programme d'attribution d'actions gratuites aux salariés" (Ipsen launches a share buyback program to cover its free share award program for employees). The core content details the initiation of a share repurchase mandate (buying back 600,000 shares) to cover employee stock grants. This action directly relates to changes in the company's outstanding shares or capital structure management, specifically through share repurchase. This aligns precisely with the definition for 'Transaction in Own Shares' (POS). It is not a general financing update (CAP) as it is focused solely on repurchasing shares for employee compensation, nor is it a general capital change announcement (SHA) which usually covers splits or new issuances. The document is a direct announcement of the transaction, not just a notice that a report is attached (ruling 2 does not apply).
2025-06-02 French
Ipsen S.A. - Assemblée Générale Annuelle du 21 mai 2025
AGM Information Classification · 1% confidence The document is explicitly titled "Assemblée Générale Annuelle d'Ipsen S.A. du 21 mai 2025" (Annual General Meeting of Ipsen S.A. of May 21, 2025) and states that "Toutes les résolutions soumises au vote des actionnaires ont été adoptées" (All resolutions submitted to the shareholders' vote were adopted). It details the approval of a dividend, the renewal of director mandates, and mentions presentations given during the meeting. This content directly corresponds to the purpose of an Annual General Meeting (AGM) and the reporting of its outcomes. While it mentions the results of the vote, the primary context is the meeting itself, making AGM-R the most appropriate classification over DVA (Declaration of Voting Results & Voting Rights Announcements), which is usually a standalone report of results. Since the document is a press release summarizing the AGM proceedings, AGM-R is the best fit.
2025-05-21 French
Ipsen S.A. - Annual General Meeting held on 21 May 2025
AGM Information Classification · 1% confidence The document explicitly states it is announcing the results of the 'Annual General Meeting of Ipsen S.A. held on 21 May 2025'. It details that all resolutions were adopted, including the dividend payment and director renewals. This content directly relates to the proceedings and outcomes of an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a short announcement of a report (RPA/RNS), but the substantive content of the meeting's outcome.
2025-05-21 English
Ipsen - Avril 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a table detailing the total number of shares and voting rights as of a specific date (April 30, 2025). This content directly relates to changes in the capital structure and voting rights, which aligns best with the 'Share Issue/Capital Change' category (SHA) or potentially a general regulatory filing (RNS). However, since it specifically details the total number of shares and voting rights, SHA is the most precise fit, as it covers capital structure changes, which includes the basis for voting rights calculations. It is not an earnings release, an AGM material, or a director's dealing report.
2025-05-12 French
Ipsen - April 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Monthly information relative to the total number of voting rights and shares composing the share capital" and explicitly references French regulatory articles (AMF). It provides a table detailing the total number of shares and the total number of voting rights as of a specific date (April 30, 2025). This type of periodic disclosure regarding the capital structure and voting rights is a specific regulatory requirement, but it does not fit perfectly into the defined categories like 10-K, ER, or IR. It is a specific regulatory disclosure concerning share capital and voting rights. Since it is a specific regulatory filing that doesn't match the primary definitions (like AGM, 10-K, ER, DIV, DIRS), the most appropriate fallback category is Regulatory Filings (RNS), as it is a mandatory, periodic regulatory update.
2025-05-12 English
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
AGM Information Classification · 1% confidence The document is a press release titled "Information relating to the holding of the Combined Shareholders' Meeting of 21 May 2025 of Ipsen S.A." It explicitly discusses the invitation to shareholders, the agenda (including dividend approval and director renewals), and the formalities for consulting preparatory documents for the meeting. This content directly relates to the preparation for and information disseminated regarding a general shareholders' meeting. While it contains information that might be part of a Proxy Statement (PSI), the primary focus is the announcement and logistics surrounding the AGM itself, including the publication of the notice of meeting ('avis de convocation'). Since the document is an announcement about the meeting and its associated materials, and it is not the final voting results (DVA) or the full proxy solicitation material itself, the most fitting category is AGM Information (AGM-R), as it details the event and its preparatory documents. It is not a short announcement linking to a full report, but rather the substantive notice itself.
2025-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.